Legend Capital

Legend Capital, established in 2001 and based in Beijing, China, is a prominent venture capital firm and a subsidiary of Legend Holdings Ltd. The firm focuses on investing in high-growth ventures primarily within China or related markets, managing approximately US$700 million across multiple funds. Legend Capital emphasizes early-stage investments in the information technology sector, particularly in network applications and services, as well as in infrastructure and professional services. Additionally, it targets mid-market growth companies in consumer goods, clean technology, healthcare, equipment manufacturing, and modern services. With a portfolio of over 60 companies, Legend Capital actively supports its investments by providing extensive business resources and tailored services, aimed at enhancing business development and brand building in the Chinese market.

Cai Ph.D., Daqing

Managing Director

Chen, Hao

Managing Director and Head of Investment

Raymond Chen

Co-Chief Investment Officer

Chen, Rui

Managing Director

Frank Hong

Managing Director

Henry Haiquan Ji

Executive Director

Kang, Yi

Director

Richard Li

President

Li, Jiaqing

Managing Director

Ouyang, Xiangyu

Managing Director

Joon Park

Executive Director

Fan, Qihui

Executive Director

Jenking Shao

Managing Director and Partner

Zhenxing Shao

Partner / Managing Director

Jeff Wang

Managing Director

Wang, Junfeng

Managing Director

Wang, Nengguang

Managing Director and CFO

Piau-Voon Wang

COO

Tony WANG

VP

Ge Xinyu

Managing Director

Quan Zhou

Managing Director, Partner

Hank Zhou

Executive Director

Hongbin Zhou

Managing Director

William Wen

Executive Director

494 past transactions

Core Medical Technology

Series D in 2025
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.

Easy Flow

Series A in 2025
Easy-Flow is committed to efficiently creating a complete set of solutions in the field of peripheral interventional devices.

Force Inspiration

Angel Round in 2025
Force Inspiration is a start-up focusing on embodied intelligence technology. The company mainly engages in technology development, technical consulting, software development, basic artificial intelligence software development, information system integration services, intelligent robot research and development and sales, and industrial robot manufacturing and sales.

Zhongke Guosheng

Series A in 2025
Zhongke Guosheng is research and development firm that designs and manufactures furan-based bio-based materials.

TOPI Imaging Technology

Series E in 2025
TOPI Imaging Technology is a medical device firm providing OCT retinal diagnostic system and sweep optical biometer.

X Square

Seed Round in 2025
X Square is a company focused on developing universal embodied large models for robots, aiming to create a universal brain-cerebellum system that offers comprehensive capabilities from perception to action.

AiCheng Technology

Series B in 2025
Suzhou Aicheng Technology is an organization that seamlessly integrates research and development (R&D) with production processes.

DeepWise

Venture Round in 2025
Beijing DeepWise Science and Technology Co., Ltd. specializes in artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and headquartered in Beijing, the company focuses on the early screening and diagnosis of various malignant diseases, including lung and breast cancer. It serves a diverse clientele, including hospitals, medical centers, and third-party imaging facilities. DeepWise's innovative software leverages advanced technology to improve diagnostic accuracy and efficiency, facilitating online consultations and data analysis through cloud-based solutions. By providing these services, DeepWise aims to support healthcare providers in both domestic and international markets in their efforts to detect and treat diseases effectively.

Picea Motion

Series A in 2025
Picea Motion is a precision harmonic drive company that specializes in the development and production of harmonic speed reducers.

Volant Aerotech

Series B in 2024
Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.

TBSTest

Series D in 2024
TBSTest Technology is a developer and manufacturer of automatic test equipment for integrated circuits, specializing in ultra-large-scale integrated circuit testing. Founded in 2017 and headquartered in Beijing, China, with additional offices in Xi’an and Shanghai, as well as Suwon, South Korea, the company provides a comprehensive range of products, including test boards, software solutions, and memory systems. TBSTest Technology also offers pre-sales and after-sales support for its equipment, accessories, and software systems, along with application development projects. The company serves a diverse clientele, including clients engaged in integrated circuit design and production, as well as scientific research institutions and educational establishments.

Chuangrui Spectrum

Seed Round in 2024
Chuangrui Spectrum specializes in the design and manufacture of time-resolved spectroscopy devices and equipment. Chuangrui Spectrum focuses mainly on research and development, as well as the manufacture and marketing of high-end scientific research equipment.

Zhipu AI

Venture Round in 2024
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

Angitia Biopharmaceuticals

Series C in 2024
Angitia Biopharmaceuticals is a global biotechnology company dedicated to discovering and developing innovative therapeutics for serious musculoskeletal diseases. The company focuses on researching and creating breakthrough therapies aimed at treating conditions affecting bones, muscles, and joints. By prioritizing the development of novel drugs, Angitia Biopharmaceuticals aims to improve patient outcomes and facilitate recovery from severe musculoskeletal ailments.

Allink Biotherapeutics

Series A in 2024
Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.

Hohem

Series B in 2024
Hohem is a camera gimbal developer specialized in the research, development, and design of drone flight control and image stabilization systems. Its key products are automatic face tracking shooting stabilizer, Bat vision positioning multi-rotor flight control system, Bfly multi-rotor flight control system, and Bee cross-country multi-rotor flight control system.

Nuwacell

Series B in 2024
Nuwacell focuses on the research and development, production and clinical transformation application of iPSC-derived cell therapy products.

MacroLux

Series B in 2024
MacroLux is a medical technology company that specializes in endoscopic interventional solutions for diagnosis and treatment. The company focuses on developing devices that enhance the detection and treatment of conditions in urology, respiratory, and digestive health. By offering advanced endoscopic therapies, MacroLux aims to improve patient outcomes through earlier diagnosis and more effective treatment options, catering to a wide range of medical customers.

Zhipu AI

Series D in 2024
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

Infinigence

Series A in 2024
Infinigence is dedicated to providing AGI computing power solutions based on its large model energy efficiency optimization tools, with the goal of resolving the challenge of efficient and unified deployment of large model algorithms to large computing power chips.

Ruicycle

Series C in 2024
Ruicycle is a high-tech company that focuses on the comprehensive recycling and utilization of lithium batteries.

Ensurge Medical

Series A in 2024
Ensurge Medical is a medical equipment developer, specializing in research, development, production, and sales of intelligent medical products like surgical energy instruments and ultrasonic scalpels.

Xellar Biosystems

Seed Round in 2024
Xellar Biosystems is a biotechnology company that focuses on enhancing drug discovery and development through the integration of artificial intelligence and machine learning. The company offers a research platform that combines advanced computational methods with large-scale wet-lab experiments. This approach allows researchers to utilize simplified models and reductionistic tools, streamlining the processes of drug testing and treatment analysis. By leveraging these technologies, Xellar Biosystems aims to accelerate the development of new pharmaceuticals, ultimately contributing to more efficient and effective healthcare solutions.

Volant Aerotech

Series A in 2024
Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.

DK Medtech

Series E in 2024
DK Medtech, founded in 2015 and headquartered in Suzhou, China, specializes in the development and production of balloon catheter medical devices. The company is recognized as a leader in the medical device industry, focusing on innovative technologies that aim to meet the evolving challenges in healthcare. Through its commitment to excellence, DK Medtech strives to create impactful solutions that enhance patient care and improve medical outcomes.

Chaitin Tech

Venture Round in 2024
Beijing Chaitin Tech Co., Ltd. is a technology-oriented security company focused on addressing Internet security challenges. With a highly skilled research and development team, Chaitin Tech specializes in creating customized security products and services aimed at enhancing the security capabilities of enterprises. The company develops innovative web application security solutions that protect critical assets from evolving cyber threats. By leveraging advanced technologies and methods, Chaitin Tech strives to improve domestic security levels while aligning with global standards in cybersecurity.

Zhongke Guosheng

Venture Round in 2024
Zhongke Guosheng is research and development firm that designs and manufactures furan-based bio-based materials.

MS ENERGY

Series D in 2024
MS Energy is a technology-driven enterprise that specializes in providing green energy solutions.

Dearer Medical

Series C in 2024
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company emphasizes research and development to create both practical and fashionable color contact lenses, catering to a diverse customer base. Through its innovative approach, Dearer Medical aims to enhance the user experience while addressing the aesthetic and functional needs of contact lens wearers.

MacroLux

Series A in 2024
MacroLux is a medical technology company that specializes in endoscopic interventional solutions for diagnosis and treatment. The company focuses on developing devices that enhance the detection and treatment of conditions in urology, respiratory, and digestive health. By offering advanced endoscopic therapies, MacroLux aims to improve patient outcomes through earlier diagnosis and more effective treatment options, catering to a wide range of medical customers.

Sunshine Hydrogen

Series A in 2024
Sunshine Hydrogen designs and manufactures its own PWM hydrogen production power supply.

Leapstack

Series C in 2023
Leapstack is an insurance technology company based in Shanghai, with additional offices in Beijing and Nanjing. Founded in February 2016, it focuses on developing big data artificial intelligence solutions tailored for commercial insurance companies and social security management agencies. The company's platform enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, anti-fraud measures, and compliance identification. By addressing inefficiencies in the industry, Leapstack aims to improve operational effectiveness and provide comprehensive data analysis and management tools for its clients.

Rhino Medical

Series A in 2023
Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments

Lingtai Krypton Biotechnology

Seed Round in 2023
Lingtai Krypton Biotechnology is an innovative corporation that specializes in the development of lncRNA drugs.

Angitia Biopharmaceuticals

Series B in 2023
Angitia Biopharmaceuticals is a global biotechnology company dedicated to discovering and developing innovative therapeutics for serious musculoskeletal diseases. The company focuses on researching and creating breakthrough therapies aimed at treating conditions affecting bones, muscles, and joints. By prioritizing the development of novel drugs, Angitia Biopharmaceuticals aims to improve patient outcomes and facilitate recovery from severe musculoskeletal ailments.

Rxilient

Venture Round in 2023
Rxilient is a company that specializes in providing contract development and manufacturing organization (CDMO) services for the pharmaceutical sector. It manufactures and distributes a range of pharmaceutical products aimed at addressing unmet medical, health, and beauty needs. The company offers a comprehensive portfolio of dermatology and medical aesthetic products, developed with a scientific approach, to support its clients in meeting various requirements for skin health and aesthetics. Through its services, Rxilient aims to enhance the effectiveness and accessibility of health and beauty solutions in the market.

Alioth

Series A in 2023
Elios focusing on the development and application of pharmaceutical process technology and related products. The company is dedicated to providing high-quality separation and purification solutions that comply with domestic and international regulations to pharmaceutical companies. In order to meet GMP requirements, Elios established its own production bases in Lingang, Shanghai, and Hangzhou. It has process development labs, verification labs, and filtration product R&D centers, as well as a research and development team led by membrane technology scientists to better safeguard supply chain security.

LEADRIVE

Series D in 2023
LEADRIVE is a technology company specializing in the research, development, production, and sales of drive solutions for new energy vehicles, as well as high-performance domestic power semiconductor modules. The company develops advanced motor controllers and power modules tailored for new energy vehicles, which have been adopted by over ten models from leading domestic and international OEMs and Tier-1 suppliers. In addition to its focus on vehicle technology, LEADRIVE invests in innovative solutions for renewable energy sources, including wind and solar power, and energy storage systems. The company has achieved significant advancements in localizing power semiconductor modules and collaborates with Rohm Semiconductor to enhance the development of silicon carbide modules. This partnership aims to improve efficiency and performance across various applications, from semiconductor devices to vehicle-level integration.

Ligatech Bioscience

Series D in 2023
Shanghai Ligatech Bioscience Co., Ltd. is a company based in Qingpu, China, founded in 2014, dedicated to the design, research and development, production, and sales of medical devices specifically for orthopedic sports medicine. The company develops a variety of products, including molecular weight polyethylene sutures and striped titanium plates, as well as artificial ligaments and fixation systems. In addition to its product offerings, Ligatech Bioscience provides technical advice and services to users, aiming to deliver comprehensive medical solutions tailored for sports professionals. The company emphasizes innovation in its development of biomedical materials and equipment, including imaging systems powered by artificial intelligence and various active devices and implants.

Saige Research

Series B in 2023
Saige Research is a company that focuses on providing artificial intelligence solutions specifically for the manufacturing sector, particularly in the area of industrial inspection and quality control. The firm has developed a deep learning vision inspection platform that addresses the challenges faced by inspectors, enhancing work efficiency. This technology offers capabilities such as power detection, speed detection, and versatility, allowing for greater convenience in development. By automating the inspection process, Saige Research aims to deliver optimal AI solutions that improve quality assurance in manufacturing environments.

Zhipu AI

Series B in 2023
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

HC Scientific

Series B in 2023
HC Scientific (Chengdu) L.L.C., founded in early 2016, focuses on developing intelligent solutions within the life sciences sector. The company aims to be a trusted partner for global clients by offering innovative products, including genetic testing instruments, reagents, and software. These products are primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is recognized as a national high-tech enterprise, emphasizing autonomous research and the development of intellectual property. The company participates in significant national and provincial scientific initiatives and is supported by a team of experts, including returning PhDs. Its product offerings streamline complex tasks for life science practitioners, delivering high-throughput, automated, and cost-effective genetic testing solutions while creating value for collaborative partners.

Wepure

Seed Round in 2023
Wepure develops, manufactures, and distributes nano-microspheres made of silica gel and resin.

Jinqirui Biology

Series C in 2023
Jinqirui Biology is a biotechnology company that focuses on the research and development, manufacturing, production & sales of vitro diagnostics equipment and reagents.

Boyin Hearing

Series A in 2023
Boyin Hearing offers a comprehensive selection of hearing treatments for persons suffering from hearing loss.

Litecore

Venture Round in 2023
Litecore is a manufacturer of optoelectronic devices and processors for broadband, large data centers, and information security.

SpacemiT

Series A in 2023
SpacemiT is a computing chip company that specializes in the development and manufacture of next-generation RISC-V architecture chips. The company aims to create natively integrated cloud-edge-device architectures, delivering powerful computing solutions that combine both hardware and software optimization. By focusing on high-performance CPUs, SpacemiT seeks to establish itself as a significant player in the global computing landscape, providing enhanced cloud computation capabilities and high-performance computing resources to its users. Through its innovative approach, the company is positioned to play a crucial role in meeting the growing demands for computing power in the digital age.

Using.AI

Seed Round in 2023
Using.AI is an AI application service provider focused on enhancing the advanced manufacturing industry through innovative technology. The company specializes in machine vision, robotics learning, and machine learning, developing self-learning solutions that optimize manufacturing processes. Its products are designed to benefit sectors such as OLED, optics components, and semiconductor devices, contributing to significant advancements in efficiency and performance within these markets.

Dipeak

Angel Round in 2023
Dipeak is a big data computing and artificial intelligence company that helps businesses traverse the AI era. Dipeak offers computer software services connected to data intelligence engines that integrate computing intelligence.

Tailan New Energy

Series B in 2023
Tailan New Energy is co-founded by lithium battery R&D experts introduced by the national high-level overseas talent project and a senior domestic industrialization team, focusing on the technological development and industrialization of new solid-state lithium batteries and key lithium battery materials.

Sinsegye

Seed Round in 2023
Sinsegye is a product-driven enterprise that specializes in providing industrial control supercomputing infrastructure. The company develops and supplies industrial intelligence computers and software aimed at enhancing industrial automation and intelligence. Its offerings focus on advanced manufacturing, high-end equipment manufacturing, new energy, and industrial IT innovations. By delivering these solutions, Sinsegye enables users to transform the landscape of the industrial computing market.

BRC Biotechnology

Seed Round in 2023
BRC Biotechnology focuses on providing quality testing services for biopharmaceutical compliance, primarily supporting biological agents. The company is involved in the evaluation of biopharmaceutical products, including cell and gene therapies, nucleic acid medications, and vaccines. Additionally, BRC Biotechnology engages in drug discovery and the development of diagnostic equipment, aiming to deliver potential treatments to patients within the biotechnology sector.

CoJourney

Series A in 2023
CoJourney is a CDMO platform for gene therapy that combines plasmid, viral vector, and mRNA generation, analysis, and detection.

Open Source China

Series B in 2023
Open Source China is a prominent community focused on open source technology, providing a platform for IT developers to discover, utilize, and exchange open source software. The community offers various resources, including open source software libraries, code sharing, discussion forums, and collaborative translation services. It serves as a hub for technical support, allowing users to seek answers to software-related questions and access relevant information. By fostering collaboration and knowledge sharing, Open Source China promotes the development and application of open source technologies among domestic developers, enhancing their ability to innovate and improve these technologies.

Chuangrui Spectrum

Angel Round in 2023
Chuangrui Spectrum specializes in the design and manufacture of time-resolved spectroscopy devices and equipment. Chuangrui Spectrum focuses mainly on research and development, as well as the manufacture and marketing of high-end scientific research equipment.

Bio-Engine

Series C in 2023
Bio-Engine is a developer of high-density serum-free suspension culture technology for animal cells. Its main products include HEK293 cell serum-free medium, PK15 cell serum-free medium, etc., which can be applied to antibodies, recombinant proteins, human and livestock. Virus vaccine, cell therapy and other fields.

TriApex

Series C in 2023
TriApex is an innovative CRO dedicated to providing disease-oriented one-stop solutions to enable R&D for global pharmaceutical enterprises and research institutions.

DentaFilm

Series B in 2023
DentaFilm is a provider of oral intelligent equipment and a full-chain platform (FICP), concentrating on the advancement of both digital cloud platforms and oral intelligent equipment. It focuses on oral equipment for data collection, data storage, data transmission, data management, and data applications, covering clinic 2D, and 3D image data, CAD/ CAM design, clinic ERP system, PMS, equipment IoT intelligent management.

N1 Life

Seed Round in 2023
N1 Life is a biomedical company dedicated to drug discovery and the development of precision drug combinations (PDC) aimed at addressing anti-tumor needs. The company focuses on innovative drug delivery technologies that seek to bridge the gap between research and clinical application. By leveraging disruptive technology, N1 Life aims to reduce both the cost and timeline associated with drug development, thereby facilitating the healthcare industry in meeting the unmet medical needs of both humans and companion animals.

Rongke Power

Series B in 2023
Rongke Power offers production services for energy storage battery equipment. They sell items from the VPower, TPower, and UPowertm ranges, among other product lines. is a provider of services and a fully independent intellectual property right.

Tripod Preclinical Research

Funding Round in 2023
Tripod is a Contract Research Organization in the biopharmaceutical space that provides preclinical research services for global pharma companies, R&D enterprises and institutes, and medical device developers. Tripod (TPR) is dedicated to nonclinical research (drug safety evaluation) for the candidates of new chemical entity (NCE), food additives, biologics,pesticides,veterinary drugs, and new cosmetics.

ZStack

Series C in 2023
ZStack is a provider of cloud computing services focused on making cloud technology more accessible for enterprises across various industries, including government, finance, education, and manufacturing. The company offers a range of solutions, including private and hybrid cloud systems, mini hyper-converged machines, and a cloud management platform. Additionally, ZStack provides enterprise-class distributed storage and other cloud-related products, enabling businesses to manage their data center resources—covering computing, networking, and storage—under a unified framework. With a client base of over 2,500 enterprise users, ZStack has also formed partnerships with more than 250 cloud vendors to enhance its ecosystem and channel offerings.

SJ Semi

Series C in 2023
SJ Semi is a MEOL foundry focused on front-end wafer manufacturing and quality systems. The company specializes in bumping, Cu pillar, RDL, and testing services for 12" wafers while investing in R&D for fan-out, TSV, interposer, and 3D technologies. With over a decade of experience, SJ Semi aims to support advancements in the semiconductor market.

CMind-SEMI

Series A in 2023
CMind is committed to becoming the new global leader in smartphone communication chips by concentrating on 4G and 5G advanced wireless communication chips and complete solutions.

MacroLux

Series A in 2023
MacroLux is a medical technology company that specializes in endoscopic interventional solutions for diagnosis and treatment. The company focuses on developing devices that enhance the detection and treatment of conditions in urology, respiratory, and digestive health. By offering advanced endoscopic therapies, MacroLux aims to improve patient outcomes through earlier diagnosis and more effective treatment options, catering to a wide range of medical customers.

ProBio Inc.

Series C in 2023
ProBio Inc. is a one-stop biopharmaceutical R&D and production platform. It provides end-to-end services for cell and gene therapy drugs, vaccine and biopharmaceutical discovery, antibody protein drugs.

Life Biosciences

Series A in 2022
Life Biosciences provides animal behaviour analysis services. Their services include blood biochemistry, routine blood testing, pathological staining, immunohistochemistry, fluorescence, molecular experiments, cell experiments, flow cytometry, x-ray irradiation, and nuclear magnetic resonance.

Polarisic

Seed Round in 2022
Polarisic specializes in the development of advanced measurement and imaging chip products, primarily utilizing single-photon avalanche diode (SPAD) technology. The company offers two main product lines: direct photon time-of-flight (dToF) measurement chips and low-light imaging chips. The dToF chips are designed for applications such as Unmanned Aerial Vehicle (UAV) height determination, obstacle avoidance, navigation for automated guided vehicles (AGVs), and smart perception in the Internet of Things (IoT). The low-light imaging chips feature high sensitivity and pixel digitization capabilities, making them suitable for night vision systems, security monitoring, smart industrial measurement, and enhanced smartphone photography. Polarisic is recognized for its technological innovations in dToF detection, high-speed digital processing, detection algorithm fusion, and system integration.

Zhongke Guosheng

Seed Round in 2022
Zhongke Guosheng is research and development firm that designs and manufactures furan-based bio-based materials.

ClinBrain

Series C in 2022
ClinBrain develops a hospital information integration platform aimed at improving healthcare services through the digitization and standardization of patient data alongside medical and clinical data. This platform is designed to enhance the efficiency of medical research by providing hospitals with comprehensive healthcare big data services. By facilitating the integration of diverse data sources, ClinBrain supports healthcare professionals in making informed decisions and advancing medical research initiatives.

Sifli Technologies

Series A in 2022
Sifli Technologies specializes in the design and development of chips for embedded artificial intelligence and Internet of Things (IoT) applications. The company creates platforms that facilitate data collection and processing for IoT sensors, as well as inferential processing for edge artificial intelligence. Its products support a range of applications, including smart wearables, medical and health equipment, home automation, intelligent terminals, industrial instruments, and intelligent buildings. By focusing on these areas, Sifli Technologies aims to enhance the functionality and efficiency of connected devices across various industries.

Easy Flow

Angel Round in 2022
Easy-Flow is committed to efficiently creating a complete set of solutions in the field of peripheral interventional devices.

GBase

Post in 2022
GBase is a Chinese company that specializes in developing database software solutions. It serves a diverse range of industries, including finance, telecommunications, government, energy, transportation, and national defense. By providing domestic-developed software, GBase enables enterprises to leverage robust database technologies tailored to their specific needs. The company's focus on serving critical sectors underscores its commitment to enhancing data management and operational efficiency for its clients.

Sinsegye

Seed Round in 2022
Sinsegye is a product-driven enterprise that specializes in providing industrial control supercomputing infrastructure. The company develops and supplies industrial intelligence computers and software aimed at enhancing industrial automation and intelligence. Its offerings focus on advanced manufacturing, high-end equipment manufacturing, new energy, and industrial IT innovations. By delivering these solutions, Sinsegye enables users to transform the landscape of the industrial computing market.

Alioth

Series A in 2022
Elios focusing on the development and application of pharmaceutical process technology and related products. The company is dedicated to providing high-quality separation and purification solutions that comply with domestic and international regulations to pharmaceutical companies. In order to meet GMP requirements, Elios established its own production bases in Lingang, Shanghai, and Hangzhou. It has process development labs, verification labs, and filtration product R&D centers, as well as a research and development team led by membrane technology scientists to better safeguard supply chain security.

VectorBuilder

Series C in 2022
VectorBuilder is an online platform specializing in vector cloning and gene delivery solutions, catering to a range of needs from basic scientific research to clinical applications. The platform enables researchers to design and order custom gene delivery vectors efficiently, streamlining the process of vector construction and production. VectorBuilder offers a comprehensive suite of services, including vector customization, virus packaging, and advanced capabilities in adeno-associated virus capsid engineering. Additionally, the company provides Contract Research Organization (CRO) services and operates state-of-the-art facilities compliant with Good Manufacturing Practices (GMP), ensuring high-quality gene delivery tools for life sciences research and drug development.

GalaxySpace

Series D in 2022
GalaxySpace is a satellite manufacturer based in Haidian, China, founded in 2016. The company specializes in developing and building a low Earth orbit (LEO) broadband satellite constellation and a 5G communication network. GalaxySpace offers various satellite applications, including monitoring systems for airports, parking, and oil reserves, as well as land assessment services. Their product range includes communication payloads, phased array antennas, power management systems, solar panels, and core platform components. Additionally, the company provides one-stop artificial intelligence satellite launch services, facilitating convenient communication and information access for clients while reducing network costs.

Shuhai Supply Chain

Series B in 2022
Shuhai Supply Chain Logistics is a supply chain service provider specializing in solutions for the food industry, particularly catering businesses. Established in June 2011 and headquartered in Beijing, China, the company offers a comprehensive range of services that include sales, procurement, production, quality assurance, warehousing, and transportation. Shuhai operates a modern cold chain logistics center and food processing plants, ensuring the delivery of fresh and high-quality ingredients to restaurant owners. Recognized by industry authorities and customers alike, Shuhai has emerged as a benchmark enterprise in the supply chain field, highlighting its commitment to excellence in service delivery.

LEADRIVE

Series C in 2022
LEADRIVE is a technology company specializing in the research, development, production, and sales of drive solutions for new energy vehicles, as well as high-performance domestic power semiconductor modules. The company develops advanced motor controllers and power modules tailored for new energy vehicles, which have been adopted by over ten models from leading domestic and international OEMs and Tier-1 suppliers. In addition to its focus on vehicle technology, LEADRIVE invests in innovative solutions for renewable energy sources, including wind and solar power, and energy storage systems. The company has achieved significant advancements in localizing power semiconductor modules and collaborates with Rohm Semiconductor to enhance the development of silicon carbide modules. This partnership aims to improve efficiency and performance across various applications, from semiconductor devices to vehicle-level integration.

Nuclei System Technology

Venture Round in 2022
Nuclei System Technology is a pioneer in China for the commercialization of RISC-V processor licensing. The company focuses on the development of high-performance and low-power processors, along with their associated system-on-chip (SoC) platforms, aimed at meeting the increasing demand for embedded system applications globally. Nuclei's semiconductor technology is tailored for smart electronics, telecommunications, and computer processing cores. It specializes in creating configurable 32/64-bit RISC-V processors designed for artificial intelligence of things (AIoT) applications, thus delivering innovative solutions to its customers.

APTBIO

Series B in 2022
APTBIO was initiated by Shanghai Institutes for Biological Sciences under Chinese Academy of Sciences in 2004, and is mainly engaged in the application of mass spectrometry technology. The so-called mass spectrometry technology is to measure the quality of protein molecules to carry out the identification of protein molecules, the modification of protein molecules and the study of protein molecule interactions.

Ruicycle

Series B in 2022
Ruicycle is a high-tech company that focuses on the comprehensive recycling and utilization of lithium batteries.

CMind-SEMI

Series A in 2022
CMind is committed to becoming the new global leader in smartphone communication chips by concentrating on 4G and 5G advanced wireless communication chips and complete solutions.

Tianfu

Series C in 2022
Tianfu is a software enterprise. The company serves domestic and foreign manufacturing companies, domestic military units, universities, and scientific research institutes. The company's services include smart design solutions, industrial AI operation and maintenance, and software custom development. It also provides customized development services for corporate customers, including CAE pre-processing development.

AKA Robotics

Series A in 2022
AKA Robotics specializes in the development, manufacturing, and sale of specialized and industrial robots, as well as intelligent equipment. The company provides innovative solutions for rust removal, cleaning, deicing, testing, spraying, and polishing across various industries, including shipbuilding, petrochemicals, wind power, and offshore platforms. By utilizing advanced robotic technologies, AKA Robotics aims to enhance efficiency and safety, enabling workers to avoid hazardous environments characterized by high risks and pollution. The company's commitment to improving operational processes supports enterprises in their transformation and upgrade efforts while promoting sustainable development.

Digital Enhancement

Seed Round in 2022
Digital Enhancement was formed in 2019 with the goal of improving RF performance with cutting-edge digital technologies. It offers the world's top DFE solutions to reshape radio linearization performance for 5G base stations, WiFi, and mobile devices, among others, in order to fulfill the evolving needs of high-frequency, high-bandwidth, small size, and low-power consumption. Digital Enhancement offers the leading DFE (digital front end) solution in the world. It may greatly increase important RF indicators such as bandwidth, linearity, efficiency, and output of the power amplifier at a low cost by using a unique and innovative CFR (Crest Factor Reduction) + DPD (digital predistortion) algorithm.Digital Enhancement was formed in 2019 with the goal of improving RF performance with cutting-edge digital technologies. It offers the world's top DFE solutions to reshape radio linearization performance for 5G base stations, WiFi, and mobile devices, among others, in order to fulfill the evolving needs of high-frequency, high-bandwidth, small size, and low-power consumption. Digital Enhancement offers the leading DFE (digital front end) solution in the world. It may greatly increase important RF indicators such as bandwidth, linearity, efficiency, and output of the power amplifier at a low cost by using a unique and innovative CFR (Crest Factor Reduction) + DPD (digital predistortion) algorithm.

TOPNC

Series D in 2022
TOPNC is a developer of intelligent manufacturing equipment and process solutions, primarily focusing on the aerospace sector. The company specializes in CNC technology, precision transmission technology, and advanced process technology. TOPNC produces CNC machine tools and other major manufacturing equipment that are essential in high-end manufacturing fields. Over time, it has established a reputation for innovation in domestic CNC equipment, providing tailored solutions for aerospace vehicles, machine tools, and general assembly production lines.

JoyMed Technology

Series B in 2022
JoyMed Technology specializes in the research and development, registration, and manufacturing of medical devices, offering comprehensive solutions to medical equipment manufacturers. The company focuses on creating innovative and reliable technologies while ensuring high-quality product standards. By providing services such as device design, risk management, marketing, and product verification and validation, JoyMed Technology helps clients streamline their processes and reduce time to market. The firm aims to be a trusted partner for both domestic and international medical device companies, particularly assisting small and medium-sized enterprises in navigating the complexities of the medical product market. Through a flexible cooperation model and experienced team design, JoyMed Technology seeks to foster mutual growth with its customers.

Huili Bio

Series A in 2022
Huili Bio is a next-generation synthetic biology enzyme computational design platform.

ClinChoice昆翎

Series E in 2022
ClinChoice Kunling was established in Tianjin inSince its establishment, through its own organic growth and strategic mergers and acquisitions, ClinChoice has more than 3,000 clinical R&D professionals around the world, located in hot cities and regions of domestic and foreign pharmaceutical R&D, and has developed into a local clinical CRO enterprise model supporting innovative drug device R&D. . The company adheres to the connotation of "Kunxing Zhiyuan · Ling creates the future", which means to become an ideal partner for the clinical research and development of innovative pharmaceutical devices.

TBSTest

Venture Round in 2022
TBSTest Technology is a developer and manufacturer of automatic test equipment for integrated circuits, specializing in ultra-large-scale integrated circuit testing. Founded in 2017 and headquartered in Beijing, China, with additional offices in Xi’an and Shanghai, as well as Suwon, South Korea, the company provides a comprehensive range of products, including test boards, software solutions, and memory systems. TBSTest Technology also offers pre-sales and after-sales support for its equipment, accessories, and software systems, along with application development projects. The company serves a diverse clientele, including clients engaged in integrated circuit design and production, as well as scientific research institutions and educational establishments.

Lipinyun

Series B in 2022
Lipinyun is a tencent strategic investment company. They offer a full-process intelligent sales model, from customer acquisition and screening to customer management and digital asset accumulation, for enterprises diverse sales ecology. Their integration solution helps enterprises realize the upgrade and iteration of digital business.

Nest

Series A in 2022
Nest is a manufacturer of lab equipment made of plastic. Modern production tools are employed in a huge manufacturing facility. In order to offer their end users more affordable solutions and laboratory supplies, they continue to study and create new fundamental supplies suitable for life sciences research.

Tailan New Energy

Series A in 2022
Tailan New Energy is co-founded by lithium battery R&D experts introduced by the national high-level overseas talent project and a senior domestic industrialization team, focusing on the technological development and industrialization of new solid-state lithium batteries and key lithium battery materials.

Senscomm Semiconductor

Series A in 2022
Senscomm Semiconductor Co., Ltd. is a fabless semiconductor company founded in 2018 and based in Suzhou, China. The company focuses on developing and providing innovative semiconductor solutions for various applications, including augmented reality (AR), virtual reality (VR), the Internet of Things (IoT), and electric vehicles (EV). Since its inception, Senscomm has successfully launched over 20 products to meet the growing global demand in these high-tech sectors.

FIT2CLOUD

Series D in 2022
FIT2CLOUD, established in 2014, is a prominent provider of Multi-Cloud Management Platform solutions in China. The company focuses on enhancing the cloud management experience for enterprise customers navigating multi-cloud environments, addressing challenges related to IT operation security and continuous application delivery. FIT2CLOUD offers a range of products, including its Cloud Management Platform, JumpServer (an open-source fortress machine), DataEase (an open-source data visualization and analysis platform), and MeterSphere (an open-source continuous testing platform). Through these offerings, FIT2CLOUD enables enterprises to effectively manage and control their cloud services, thereby facilitating digital transformation and improving operational efficiency.

ZHIYI TECH

Series B in 2022
Zhiyi Tech develops a supply chain platform for intelligent clothing design. They offer services for digitalized trend forecasting, design selection, and supply chain organization. They provide clothing companies with core functions such as fashion trend prediction, design empowerment, and style recommendation, and expand to the downstream of the industrial chain via the SaaS portal, providing one-stop design and flexible production supply chain platform services.

Reliable Med

Series A in 2022
Reliable Med is a medical device developer.

Qingwei Intelligent Technology

Series B in 2022
Qingwei Intelligent Technologies creates artificial intelligence chips that may be reconfigured to improve energy efficiency. The company's chips are designed with low power consumption, intelligent speech and visual features in mind, providing customers with a better consumer electronics experience and application.

Tichuang Biotechnology

Series A in 2022
Tichuang Biotechnology is an enterprise that realizes the industrialization and commercialization of cross-material types. Tichuang Biotechnology provides integrated solutions for production, education, and research in order to meet the needs of multiple industries for green and high-quality raw materials. Tichuang Biotechnology's strain library and component library platform advences breakthroughs in mass production and universality.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.